Indications for Initiating Antiretroviral Therapy for HIV-1 Infections
TABLE 59-4. Indications for Initiating Antiretroviral Therapy for HIV-1 Infections
Clinical Category | CD4+ T-Cell Count | Plasma HIV RNA | Adult and Postpartum Recommendation | Pregnancy Recommendation |
Symptomatic (AIDS or severe symptoms) | Any value | Any value | Treat | Treat |
Asymptomatic AIDS | < 200/mm3 | Any value | Treat | Treat |
Asymptomatic | 200-350/mm3 | Any value | Treatment should be offered, although controversial | Treat |
Asymptomatic | > 350/mm3 | > 100,000/mL | Some recommend initiating therapy, recognizing that the 3-year risk for untreated patients to develop AIDS is > 30%; in the absence of increased levels of plasma HIV RNA, others recommend deferring therapy and monitoring the CD4+ T-cell count and HIV RNA level more frequently; outcome data with therapy are lacking | Treat |
Asymptomatic | > 350/mm3 | < 100,000/mL | Most recommend deferring therapy and monitoring CD4+ T-cell count, recognizing that the 3-year risk for untreated patients to develop symptomatic AIDS is < 15% | Treat |
AIDS = acquired immunodeficiency syndrome; HIV = human immunodeficiency virus. | ||||
From U.S. Public Health Service (2004a, 2003); updated from http://AIDSinfo.nih.gov; accessed October 29, 2004. |